$ISIS Company News 5 companies that will benef
Post# of 74549
Posted On: 08/24/2014 1:00:45 PM
$ISIS Company News
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 9:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 11:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 1:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 1:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 12:59 p.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 11:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 3:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 10:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 11:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 3:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 11:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 5:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 6:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 7:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 7:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 11:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 3:06 p.m. Dec. 10, 2012 - MarketWatch.com
Hottest Healthcare Stocks Now – PRGO WX ISIS TARO 8:30 a.m. Aug. 14, 2014 - InvestorPlace.com
UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT 10:34 a.m. Aug. 12, 2014 - benzinga.com
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog 9:10 a.m. Aug. 7, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 7, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – CBPO ISIS HAE LPNT 2:00 p.m. Aug. 5, 2014 - InvestorPlace.com
Company News for August 05, 2014 - Corporate Summary 10:10 a.m. Aug. 5, 2014 - Zacks.com
ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q2 2014 Results - Earnings Call Transcript 4:24 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: ISIS PHARMACEUTICALS INC 3:29 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – ALNY ISIS INCY HTWR 1:15 p.m. Aug. 4, 2014 - InvestorPlace.com
Insider Trading Alert - GPN, UHS And ISIS Traded By Insiders 10:30 a.m. Aug. 4, 2014 - TheStreet.com
Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential 7:36 a.m. Aug. 4, 2014 - Seeking Alpha
Isis set for milestone payment from Biogen 8:32 a.m. Aug. 1, 2014 - Seeking Alpha
Cramer's Lightning Round - 6 Biotech Picks (7/30/14) 6:35 a.m. July 31, 2014 - Seeking Alpha
ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners 10:52 a.m. July 25, 2014 - Seeking Alpha
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog 6:50 p.m. July 21, 2014 - Zacks.com
Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a) 6:01 a.m. July 17, 2014 - benzinga.com
Cramer's Lightning Round - BioMarin Deserves To Be Higher (7/14/14) 6:04 a.m. July 15, 2014 - Seeking Alpha
Cramer's Mad Money - Dean Foods Will Do Your Portfolio Good (7/10/14) 6:01 a.m. July 11, 2014 - Seeking Alpha
Post-Market Laggard: Isis Pharmaceuticals (ISIS) 7:56 p.m. July 7, 2014 - TheStreet.com
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 7:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 7:00 a.m. July 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a) 7:00 a.m. July 17, 2014 - PR Newswire - PRF
Critical Alerts For Cninsure, Freeport-McMoRan, Level 3 Communications, Electronic Arts, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx 7:00 a.m. July 16, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 3:31 p.m. July 15, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Critical Alerts For General Electric, Deere, Isis Pharmaceuticals, Expedia, and Sears Holdings Released By InvestorsObserver 9:31 a.m. June 26, 2014 - PR Newswire - PRF
Global Diabetic Retinopathy Market 2014-2018 12:22 p.m. June 25, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing ISIS-TTR Rx 7:00 a.m. June 24, 2014 - PR Newswire - PRF
Collaborations, FDA Clearances, and Technical Updates - Analyst Notes on Isis Pharmaceuticals, DexCom, Theravance Biopharma, Intrexon and Alere 5:30 a.m. June 19, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Quarterly Changes to the NASDAQ Q-50 Index 7:15 a.m. June 16, 2014 - GlobeNewswire
Isis Pharmaceuticals Reports Final Phase 2 Data on ISIS-GCGR RX Showing Significant Reduction in HbA1c in Patients with Type 2 Diabetes 7:00 a.m. June 16, 2014 - PR Newswire - PRF
Anticipated Approval of Three New Therapies Through 2023 Will Expand Treatment Options for the Control and Relief of Motor Symptoms in Huntington's Disease 10:00 a.m. June 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 Wells Fargo Healthcare Conference 7:00 a.m. June 12, 2014 - PR Newswire - PRF
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 9:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 11:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 1:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 1:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 12:59 p.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 11:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 3:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 10:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 11:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 3:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 11:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 5:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 6:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 7:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 7:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 11:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 3:06 p.m. Dec. 10, 2012 - MarketWatch.com
Hottest Healthcare Stocks Now – PRGO WX ISIS TARO 8:30 a.m. Aug. 14, 2014 - InvestorPlace.com
UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT 10:34 a.m. Aug. 12, 2014 - benzinga.com
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog 9:10 a.m. Aug. 7, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 7, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – CBPO ISIS HAE LPNT 2:00 p.m. Aug. 5, 2014 - InvestorPlace.com
Company News for August 05, 2014 - Corporate Summary 10:10 a.m. Aug. 5, 2014 - Zacks.com
ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q2 2014 Results - Earnings Call Transcript 4:24 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: ISIS PHARMACEUTICALS INC 3:29 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – ALNY ISIS INCY HTWR 1:15 p.m. Aug. 4, 2014 - InvestorPlace.com
Insider Trading Alert - GPN, UHS And ISIS Traded By Insiders 10:30 a.m. Aug. 4, 2014 - TheStreet.com
Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential 7:36 a.m. Aug. 4, 2014 - Seeking Alpha
Isis set for milestone payment from Biogen 8:32 a.m. Aug. 1, 2014 - Seeking Alpha
Cramer's Lightning Round - 6 Biotech Picks (7/30/14) 6:35 a.m. July 31, 2014 - Seeking Alpha
ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners 10:52 a.m. July 25, 2014 - Seeking Alpha
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog 6:50 p.m. July 21, 2014 - Zacks.com
Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a) 6:01 a.m. July 17, 2014 - benzinga.com
Cramer's Lightning Round - BioMarin Deserves To Be Higher (7/14/14) 6:04 a.m. July 15, 2014 - Seeking Alpha
Cramer's Mad Money - Dean Foods Will Do Your Portfolio Good (7/10/14) 6:01 a.m. July 11, 2014 - Seeking Alpha
Post-Market Laggard: Isis Pharmaceuticals (ISIS) 7:56 p.m. July 7, 2014 - TheStreet.com
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 7:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 7:00 a.m. July 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a) 7:00 a.m. July 17, 2014 - PR Newswire - PRF
Critical Alerts For Cninsure, Freeport-McMoRan, Level 3 Communications, Electronic Arts, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx 7:00 a.m. July 16, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 3:31 p.m. July 15, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Critical Alerts For General Electric, Deere, Isis Pharmaceuticals, Expedia, and Sears Holdings Released By InvestorsObserver 9:31 a.m. June 26, 2014 - PR Newswire - PRF
Global Diabetic Retinopathy Market 2014-2018 12:22 p.m. June 25, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing ISIS-TTR Rx 7:00 a.m. June 24, 2014 - PR Newswire - PRF
Collaborations, FDA Clearances, and Technical Updates - Analyst Notes on Isis Pharmaceuticals, DexCom, Theravance Biopharma, Intrexon and Alere 5:30 a.m. June 19, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Quarterly Changes to the NASDAQ Q-50 Index 7:15 a.m. June 16, 2014 - GlobeNewswire
Isis Pharmaceuticals Reports Final Phase 2 Data on ISIS-GCGR RX Showing Significant Reduction in HbA1c in Patients with Type 2 Diabetes 7:00 a.m. June 16, 2014 - PR Newswire - PRF
Anticipated Approval of Three New Therapies Through 2023 Will Expand Treatment Options for the Control and Relief of Motor Symptoms in Huntington's Disease 10:00 a.m. June 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 Wells Fargo Healthcare Conference 7:00 a.m. June 12, 2014 - PR Newswire - PRF
(0)
(0)